- Home
- ATOS vs AKA Comparison
ATOS vs AKA Comparison
Compare ATOS & AKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- AKA
- Stock Information
- Founded
- ATOS 2009
- AKA 2018
- Country
- ATOS United States
- AKA United States
- Employees
- ATOS N/A
- AKA N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- AKA Catalog/Specialty Distribution
- Sector
- ATOS Health Care
- AKA Consumer Discretionary
- Exchange
- ATOS Nasdaq
- AKA Nasdaq
- Market Cap
- ATOS 107.2M
- AKA 110.4M
- IPO Year
- ATOS 2012
- AKA 2021
- Fundamental
- Price
- ATOS $0.84
- AKA $10.67
- Analyst Decision
- ATOS Strong Buy
- AKA Strong Buy
- Analyst Count
- ATOS 3
- AKA 3
- Target Price
- ATOS $6.17
- AKA $24.33
- AVG Volume (30 Days)
- ATOS 483.0K
- AKA 4.4K
- Earning Date
- ATOS 11-11-2025
- AKA 11-06-2025
- Dividend Yield
- ATOS N/A
- AKA N/A
- EPS Growth
- ATOS N/A
- AKA N/A
- EPS
- ATOS N/A
- AKA N/A
- Revenue
- ATOS N/A
- AKA $598,107,000.00
- Revenue This Year
- ATOS N/A
- AKA $7.29
- Revenue Next Year
- ATOS N/A
- AKA $4.10
- P/E Ratio
- ATOS N/A
- AKA N/A
- Revenue Growth
- ATOS N/A
- AKA 7.67
- 52 Week Low
- ATOS $0.55
- AKA $7.00
- 52 Week High
- ATOS $1.66
- AKA $32.25
- Technical
- Relative Strength Index (RSI)
- ATOS 60.84
- AKA 47.69
- Support Level
- ATOS $0.81
- AKA $10.02
- Resistance Level
- ATOS $0.80
- AKA $10.99
- Average True Range (ATR)
- ATOS 0.03
- AKA 0.42
- MACD
- ATOS 0.01
- AKA -0.02
- Stochastic Oscillator
- ATOS 92.67
- AKA 49.25
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About AKA a.k.a. Brands Holding Corp.
a.k.a. Brands Holding Corp is an online fashion retailer focused on acquiring and accelerating the growth of next-generation, digitally native fashion brands targeting Gen Z and Millennial customers. The brands of the company are two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company derives maximum revenue from Australia/New Zealand.